Benjamin J. Parcell
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 6
- SARS-CoV-2 and COVID-19 Research 5
- Viral gastroenteritis research and epidemiology 4
- Epidemiology 15
- Infective Endocarditis Diagnosis and Management 5
- Co-authors
- Stephen H. Gillespie (5 shared papers)Matthew T. G. Holden (3 shared papers)G. Phillips (2 shared papers)Peter J. Coote (5 shared papers)James D. Chalmers (5 shared papers)Kerry A. Pettigrew (2 shared papers)G. Orange (1 shared paper)Miguel Pinheiro (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (7 papers)Journal of Hospital Infection (4 papers)Journal of Medical Microbiology (3 papers)Antibiotics (3 papers)The Lancet Microbe (2 papers)
- Partner nations
- United KingdomJapanUnited States
In The Last Decade
Benjamin J. Parcell
41 papers receiving 406 citations
Peers
Comparison fields: 5 of 71
- Molecular Medicine 98
- Clinical Biochemistry 76
- Applied Microbiology and Biotechnology 20
- Infectious Diseases 179
- Microbiology 44
Countries citing papers authored by Benjamin J. Parcell
This map shows the geographic impact of Benjamin J. Parcell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Parcell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Parcell more than expected).
Fields of papers citing papers by Benjamin J. Parcell
This network shows the impact of papers produced by Benjamin J. Parcell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Parcell. The network helps show where Benjamin J. Parcell may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin J. Parcell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 37 | |
| 2 | 2016 | 29 | |
| 3 | 2021 | 26 | |
| 4 | 2020 | 26 | |
| 5 | 2014 | 26 | |
| 6 | 2014 | 24 | |
| 7 | 2015 | 20 | |
| 8 | 2019 | 19 | |
| 9 | 2021 | 19 | |
| 10 | 2014 | 17 | |
| 11 | 2022 | 14 | |
| 12 | 2024 | 14 | |
| 13 | 2014 | 13 | |
| 14 | 2017 | 11 | |
| 15 | 2013 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2020 | 9 | |
| 18 | 2024 | 9 | |
| 19 | 2013 | 9 | |
| 20 | 2019 | 8 |
About Benjamin J. Parcell
Benjamin J. Parcell is a scholar working on Infectious Diseases, Epidemiology, Clinical Biochemistry, Molecular Medicine and Microbiology, having authored 43 papers that have together received 418 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (12 papers), Antibiotic Resistance in Bacteria (12 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Infective Endocarditis Diagnosis and Management (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Antibiotic Use and Resistance (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Molecular Medicine (98 citations), Clinical Biochemistry (76 citations), Applied Microbiology and Biotechnology (20 citations), Infectious Diseases (179 citations) and Microbiology (44 citations). Benjamin J. Parcell has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include Stephen H. Gillespie, Matthew T. G. Holden, G. Phillips, Peter J. Coote, James D. Chalmers, Kerry A. Pettigrew, G. Orange, Miguel Pinheiro, Kate Templeton and Katarína Oravcová. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Journal of Medical Microbiology, Antibiotics and The Lancet Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.